Mesenchymal Stem Cells News and Research

RSS

Researchers treat osteogeneis imperfecta babies in utero by injecting bone-forming stem cells

Osteogeneis imperfecta (OI) is a congenital bone disease that causes stunted growth and repeated, painful fracturing. Ultrasound scans can reveal fractures already in the fetus, and now an international team of researchers from Sweden, Singapore and Taiwan have treated two babies in utero by injecting bone-forming stem cells.

17 Dec 2013

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Stem cells have a potential to develop into multiple cell types and divide without limit to replenish cells in human body throughout the life of individual.

16 Dec 2013

Sea coral could soon be used in bone grafting procedures

Sea coral could soon be used more extensively in bone grafting procedures thanks to new research that has refined the material's properties and made it more compatible with natural bone.

29 Nov 2013

Heart failure patients receiving LVAD may benefit from injection of powerful cells directly into heart

A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network, led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular assist device heart pump may also benefit from a single dose of millions of powerful cells injected directly into their heart during surgery.

19 Nov 2013

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.

19 Nov 2013

University of Wisconsin scientist to present revolutionary stem cell technology to Australian bioindustry

Internationally recognised stem cell scientist, Associate ProfessorIgor Slukvin, University of Wisconsin – Madison, is visiting Australia as the key-note speaker at a Stem Cell Meeting and Workshop in Sydney next week.

19 Nov 2013

Study finds no evidence that stem cell therapy improves vision for children with ONH

A study performed at Children's Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia. Their results are reported in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.

22 Oct 2013

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.

10 Oct 2013

Researchers discover way to use stem cells as drug delivery vehicles

A group of Brigham and Women's Hospital, and Harvard Stem Cell Institute researchers and collaborators at MIT and MGH have found a way to use stem cells as drug delivery vehicles.

5 Oct 2013

Innovative system can help manipulate stem cells to repair damaged tissues and organs

Scientists know that physical and biochemical signals can guide cells to make, for example, muscle, blood vessels or bone. But the exact recipes to produce the desired tissues have proved elusive.

19 Sep 2013

Study: Mesenchymal stem cell transplantation may help treat stress urinary incontinence

Vaginal delivery presents the possibility of injury for mothers that can lead to "stress urinary incontinence", a condition affecting from four to 35 percent of women who have had babies via vaginal delivery. Many current treatments, such as physiotherapy and surgery, are not very effective.

18 Sep 2013

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

Glioblastoma is the most common ma-lignant primary brain tumor in adults. The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide.

11 Sep 2013

Non-adherent bone marrow cell-derived mesenchymal stem cells could differentiate into neuronal-like cells

It is widely believed that bone marrow mesenchymal stem cells are highly adherent fibroblastic cells, defined as colony-forming unit-fibroblasts. Nevertheless, a few reports have shown that the non-adherent bone marrow cells can give rise to colony-forming unit-fibroblasts in vitro, and possess a certain differentiation potential.

6 Sep 2013

New recombinant antibody can recognize MSCs in umbilical cord blood

A new recombinant antibody can detect and isolate mesenchymal stem cells (MSCs), a nonembryonic source of stem cells with promising applications in tissue engineering, blood stem cell transplantation, and treatments for immune-mediated disorders.

4 Sep 2013

WPI researchers receive NIH grant to develop cell therapies for healing cardiac muscle

The National Institutes of Health (NIH) has awarded a five-year, $1.94 million grant to a biomedical research team at Worcester Polytechnic Institute (WPI) working at the forefront of cell therapies for healing cardiac muscle damaged by heart attack or chronic disease.

29 Aug 2013

Intracerebral injection of BSC may reduce post-stroke cognitive dysfunction

27 Aug 2013

BSCs may offer new approach for reducing post-stroke cognitive dysfunction

Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke, suggesting that BSCs may offer a new approach for reducing post-stroke cognitive dysfunction.

26 Aug 2013

Studies reveal potential of HB-EGF in protecting intestines from diverse types of injury

It's not often that one treatment offers therapeutic potential for multiple conditions. However, after more than two decades of research, Gail Besner, MD, principal investigator for the Center for Perinatal Research and pediatric surgeon for the Department of Pediatric Surgery at Nationwide Children's Hospital, and her team have found that this may just be the case with HB-EGF, or heparin-binding EGF-like growth factor.

21 Aug 2013

Repair of sciatic nerve defects using tissue engineered nerves

Peripheral nerve defects are very common in clinical surgery. For repair of short-segment nerve defects, freeing nerve, nerve diversions or joint flexion can be used to directly connect the two stumps of nerves by using microsurgical techniques; while for long-segment nerve defects, we require a bridging material to bridge defected nerves.

16 Aug 2013

Study: Stem cells in mouth tissue can relieve inflammatory disease

Stem cells found in mouth tissue can not only become other types of cells but can also relieve inflammatory disease, according to a new Ostrow School of Dentistry of USC study in the Journal of Dental Research.

5 Aug 2013

Mesenchymal Stem Cells News and Research

Researchers treat osteogeneis imperfecta babies in utero by injecting bone-forming stem cells

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Sea coral could soon be used in bone grafting procedures

Heart failure patients receiving LVAD may benefit from injection of powerful cells directly into heart

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

University of Wisconsin scientist to present revolutionary stem cell technology to Australian bioindustry

Study finds no evidence that stem cell therapy improves vision for children with ONH

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Researchers discover way to use stem cells as drug delivery vehicles

Innovative system can help manipulate stem cells to repair damaged tissues and organs

Study: Mesenchymal stem cell transplantation may help treat stress urinary incontinence

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

Non-adherent bone marrow cell-derived mesenchymal stem cells could differentiate into neuronal-like cells

New recombinant antibody can recognize MSCs in umbilical cord blood

WPI researchers receive NIH grant to develop cell therapies for healing cardiac muscle

Intracerebral injection of BSC may reduce post-stroke cognitive dysfunction

BSCs may offer new approach for reducing post-stroke cognitive dysfunction

Studies reveal potential of HB-EGF in protecting intestines from diverse types of injury

Repair of sciatic nerve defects using tissue engineered nerves

Study: Stem cells in mouth tissue can relieve inflammatory disease

eBook: Integrated solutions for mesenchymal stem cell research and culture eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News